Overview Traws Pharma, Inc. (Traws, we, or the Company) is a clinical stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. We are advancing novel investigational antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human health. Our product candidates are intended to be safe, with simple dosing regimens. We strive to utilize accelerated clinical t...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-31 | 2024-12-31 | 0001558370-25-004165 | EDGAR | 77K words |
| 2024-04-01 | 2023-12-31 | 0001558370-24-004525 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001558370-23-005107 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0001558370-22-004015 | EDGAR | — |
| 2021-03-18 | 2020-12-31 | 0001104659-21-038452 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001047469-20-001878 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001047469-19-001839 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001047469-18-001777 | EDGAR | — |
| 2017-03-29 | 2016-12-31 | 0001047469-17-002146 | EDGAR | — |
| 2016-03-28 | 2015-12-31 | 0001047469-16-011628 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001104659-26-097261 | EDGAR | — |
| 2025-11-13 | 2025-09-30 | 0001104659-25-110845 | EDGAR | 26K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011469 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001558370-25-007872 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015752 | EDGAR | — |
| 2024-08-15 | 2024-06-30 | 0001558370-24-012279 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001558370-24-008326 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001558370-23-019049 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001558370-23-014933 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009964 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017811 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001558370-22-013675 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-14 | 0001104659-26-097226 | EDGAR | — |
| 2026-07-31 | 0001104659-26-089220 | EDGAR | — |
| 2026-02-19 | 0001104659-26-017298 | EDGAR | 1K words |
| 2026-01-26 | 0001104659-26-006460 | EDGAR | — |
| 2026-01-13 | 0001104659-26-003071 | EDGAR | — |
| 2025-12-17 | 0001104659-25-121749 | EDGAR | — |
| 2025-12-16 | 0001104659-25-121635 | EDGAR | — |
| 2025-11-28 | 0001104659-25-116962 | EDGAR | — |
| 2025-11-13 | 0001104659-25-110829 | EDGAR | — |
| 2025-10-17 | 0001104659-25-100455 | EDGAR | — |
341 total filings indexed. 309 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001130598 |
| Ticker | TRAW |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.trawspharma.com |
| Listed | 2013-07-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TRAW (~200 tokens, structured JSON with cryptographic provenance)